Device Trial Radar · NCT06915922
YAG Laser Vitreolysis for Vitreous Floaters
Last checked: Nov 19, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
52
Actual
Start
Oct 17, 2023
Primary completion
Aug 13, 2026
Study completion Aug 13, 2026
Sponsor
- Lead sponsor
- VMR Consulting, Inc.Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- The Retina Clinic - London Ophthalmic Institute
- First posted
- Apr 8, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to measure how the quality of life, the structure of eye, and vision change after treatment for the opacities in the gel (vitreous) that fills the center of eye which cause vision disturbances commonly called "floaters". In this study the vitreous floaters are treated using a Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser. The FDA has approved the use of this laser to treat membranes in the eye.
Conditions
- Posterior Vitreous Detachment
- Myopic Vitreopathy
- VISION DEGRADING MYODESOPSIA
Interventions
Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser therapyDevice
Nd:YAG laser treatment(s) for Vision Degrading Myodesopsia (clinically significant vitreous floaters) in eyes with vitreous opacities due to myopic vitreopathy and posterior vitreous detachment (PVD).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Measures of vitreous structure by quantitative ultrasonographyTime frame: baseline, 3 months, 6 months, 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
VMR Institute for Vitreous Macula Retina
Huntington Beach, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.